Fortress BiotechFBIO
NASDAQPharmaceuticals
No cached AI snapshot yet for FBIO.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
78 employees32.20M shares outstandinglisted 2011-11-17
Next earnings ~May 5, 2026
About Fortress Biotech
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Latest News
Showing market-wide stock news
5% Treasury yields mean America’s debt bill just got a lot bigger
US30 tests 52,140 as 5% Treasury yields rewrite the equity math
Rupee languishes at six-week low ahead of Fed outcome, RBI limits losses
Gold Price Forecast: XAU/USD consolidates below $4,350 ahead of Fed decision
Bond market woes likely a factor for Fed, but intervention seen as unlikely
German Stocks Gain Ground On Oil Decline, Fed Looms
Related Stocksin Pharmaceuticals
Ready to see the live AI view on FBIO?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing FBIO side-by-side with live signals.